RBC Capital Starts Spark Therapeutics (ONCE) at Outperform
Tweet
Share
E-mailGet Alerts ONCE Hot Sheet
Price: $110.05 --0%
Rating Summary:
5 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Rating Summary:
5 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 12 | New: 12
Join SI Premium – FREE
RBC Capital initiates coverage on Spark Therapeutics (NASDAQ: ONCE) with a Outperform rating and a price target of $100.00.
For an analyst ratings summary and ratings history on Spark Therapeutics click here. For more ratings news on Spark Therapeutics click here.
Shares of Spark Therapeutics closed at $81.71 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Assumes Life360 Inc (360:AU) at Outperform
- Desjardins Starts Athabasca Oil Corp. (ATH:CN) (ATHOF) at Hold
- Desjardins Starts Headwater Exploration Inc (HWX:CN) (CDDRF) at Hold
Create E-mail Alert Related Categories
New CoverageRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
